Samsung Group’s biologic drug-development affiliate submitted a near-replica of blockbuster breast cancer drug Herceptin for regulatory approval in Europe.
Baca Berita Asal
Bagikan Berita Ini
Monday, October 3, 2016
Tech
Samsung Affiliate Seeks European Approval for Herceptin Copy
Samsung Affiliate Seeks European Approval for Herceptin Copy
Samsung Group’s biologic drug-development affiliate submitted a near-replica of blockbuster breast cancer drug Herceptin for regulatory approval in Europe.
Baca Berita Asal
Bagikan Berita Ini
Samsung Group’s biologic drug-development affiliate submitted a near-replica of blockbuster breast cancer drug Herceptin for regulatory approval in Europe.
Baca Berita Asal
Bagikan Berita Ini
0 Response to "Samsung Affiliate Seeks European Approval for Herceptin Copy"
Post a Comment